Introduction
We found a significant number of antigen-responding CD8 T cells cycling in lymph 79 nodes (LNs), spleen and (surprisingly) in the blood, a finding that opens new 80 directions for the analysis of immune responses. 1 gag, using a recombinant chimpanzee-derived adenoviral vector (ChAd3-gag) and a 87
Modified Virus Ankara (MVA-gag) for priming and boosting, respectively (12). The 88 cell cycle stages of gag-specific CD8 T cells were analyzed using Hoechst 33342, a 89 DNA dye, and anti-Ki67 mAb (14, 15) . Step 3 uses Forward Scatter-A (FSC-A) and Side Scatter-A (SSC-A) profiles to 95 identify certain leukocyte populations. Lymphocytes tend to have low SSC-A and 96 medium-low FSC-A, whereas granulocytes have high SSC-A, and are normally 97 excluded from the canonical 'narrow' gate used for lymphocyte studies (16-19) ( Fig.  98 
1B,
Step 3, 'narrow'). However, we noticed an unusual population of cells with high 99 SSC-A that appeared only in vaccinated spleens and contained a significant number 100 of antigen-specific lymphocytes (Fig. 1B, Step 3, arrow). When we enlarged our 101 FSC-A/ SSC-A gate ( Step 3 'relaxed'), before labeling CD8 T cells ( Step 4) and 102
antigen-specific T cells (Step 5), we found a 2-6 fold greater proportion of gag-103 specific CD8 T cells in the 'relaxed' gate population than in the 'narrow' gate 104 population: not only in the spleen but also in the LNs (Fig. 1B-D) . Although this 105 gating strategy is novel for standard ex vivo studies of lymphocytes ( Fig. 1-S1 ), cells 106 with high FSC-A and high SSC-A are often included when examining in vitro 107
activated T cells (20). 108 109
In order to discriminate between gag-specific CD8 T cells in G 0 , G 1 , and S-G 2 -M, we 110 examined Ki67 expression plus DNA content, using either the 'narrow' or the 111 'relaxed' gate (Fig. 2) . We observed a striking difference in the percentages of 112 proliferating cells between the two strategies. The 'narrow' gate missed most of the 113 dividing cells in S-G 2 -M (<2%), whereas the 'relaxed' gate revealed that these cells 114 made up to 42% of the gag-specific cells in LNs and 26% in spleen ( Fig. 2A, C) . Cell 115 cycle entry and progression was accompanied by a graded increase of FSC-A, and 116 more prominently of SSC-A (Fig. 2B-C) . Proliferation was also seen after a single 117 priming dose, though the kinetics were slower and there were fewer cells in S-G 2 -M 118 (Fig. 2-S1 ). 119
120
The 'narrow' gate missed up to a third of gag-specific CD8 T cells in the blood (Fig.  121 3A), which -with the 'relaxed' gate-averaged 2% at d3, 36% at d7, and 13% at 122 d44 post-boost (Fig. 3B ). As expected (12), gag-specific cells down-modulated 123 CD62L (Fig 3-S1A-B) . A well-defined population of mitotic gag-specific CD8 T 124 cells was revealed uniquely using the 'relaxed' gate. Cells in S-G 2 -M were obvious at 125 d3 (up to 13%) and less evident at d7 when Ki67 + peaked (up to 94%), suggesting that 126
Ki67
+ cells (non G 0 ) persist in blood after mitotic cells disappear ( Fig. 3C-D ; 3-S1C-127 D). By day 44, almost all gag-specific cells were in G 0 (Fig. 3C ), suggesting that they 128 had mostly switched to a resting memory state. We also saw mitotic antigen-specific 129 CD8 T cells in blood after a single priming shot of vaccine (Fig. 3-S2) . 130
131
Hypothesizing that the increased DNA content of the expanding CD8 T cells could be 132 exploited as a marker to identify antigen-responding cells in the blood, we focussed 133 on CD62L (-) non-naïve cells), 4) CD62L (-) in S-G 2 -M (dividing non-naïve cells). At day 3, the 138 average percentage of gag-specific cells among the dividing non-naïve cells was 15-139 fold higher than among total CD8 T cells (Fig. 4C) , sometimes up to 70% (Fig 4B) , a 140 much higher proportion than observed among the other 3 populations (Fig 4B-C) . By 141 d7, the gag-specific cells comprised 40% of the dividing non-naïve and 84% of the 142 non-G 0 non-naïve population. By d44 gag-specific cells were decreased in all the 143 populations, though less evidently in the CD62L (-) 
population (Fig. 4C). Results were 144
similar, though the kinetics slower, after a single priming dose (Fig 4-S1) . Mitotic gag-specific CD8 T cells were found in the blood after a single dose of 164
ChAd3-gag, although they were fewer than after a boost with MVA-gag, possibly due 165 to slower kinetics, and/or differences in spatial distribution of antigen-responding 166 CD8 T cells inside the LNs (24) that were reflected in the blood. Further studies will 167 be necessary to elucidate whether naïve and memory cells behave differently upon 168 stimulation in vivo, whether vaccination route matters, and whether the cycling CD8 169 T cell clones in the blood comprise a special highly dividing subset and/or express 170 high affinity TCRs. 171
172
The majority of dividing CD8 T cells in blood, spleen and LNs showed increased 173 FSC-A and unusually high SSC-A, likely due to changes in mitochondria, chromatin 174 condensation, etc. (25, 26). Cells with these characteristics are usually excluded from 175 the analysis of normal lymphocytes ex vivo, for example human blood lymphocytes 176 in conditions apart from cancer. Considering that nearly all immunological studies in 177 humans use blood samples, important informations are likely to be missed, perhaps 178 leading to incorrect conclusions. For example, it was found that up to 70% of virus-179 specific CD8 T cells were Ki67 + in the blood of patients at early phases of primary 180 infections (8, 9), whereas memory-phenotype CD8 T cells from the blood of donors 181 with no apparent infections comprised about 2-10% of Ki67 + cells (27). Furthermore, 182
an early increase of Ki67 + PD-1 + CD8 T cells was observed in the blood of a subset of 183 lung cancer patients treated with checkpoint inhibitors, and it was proposed that this 184 could be relevant for antitumor effects (28). In all these studies it was suggested that 185 the Ki67 + cells were proliferating in response to a recent immunogenic stimulus (8, 9, 186 27, 28), however cells with high side scatter were discarded (9, 28), and DNA content 187
was not evaluated (8, 9, 27, 28), thus it cannot be distinguished whether the Ki67 
